BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Baber U, Mastoris I, Mehran R. Balancing ischaemia and bleeding risks with novel oral anticoagulants. Nat Rev Cardiol 2014;11:693-703. [PMID: 25367652 DOI: 10.1038/nrcardio.2014.170] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Levy JH. Discontinuation and Management of Direct-Acting Anticoagulants for Emergency Procedures. The American Journal of Medicine 2016;129:S47-53. [DOI: 10.1016/j.amjmed.2016.06.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
2 Levy JH. Discontinuation and management of direct-acting anticoagulants for emergency procedures. The American Journal of Emergency Medicine 2016;34:14-8. [DOI: 10.1016/j.ajem.2016.09.048] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
3 Chin PK, Doogue MP. Long-term prescribing of new oral anticoagulants. Aust Prescr 2016;39:200-4. [PMID: 27990047 DOI: 10.18773/austprescr.2016.068] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
4 Li X, Zuo C, Ji Q, Xue Y, Wang Z, Lv Q. Body Mass Index Influence on the Clinical Outcomes for Nonvalvular Atrial Fibrillation Patients Admitted to a Hospital Treated with Direct Oral Anticoagulants: A Retrospective Cohort Study. Drug Des Devel Ther 2021;15:1931-43. [PMID: 33986592 DOI: 10.2147/DDDT.S303219] [Reference Citation Analysis]
5 Sun KX, Cui B, Cao SS, Huang QX, Xia RY, Wang WJ, Wang JW, Yu F, Ding Y. Cost-Effectiveness Analysis of Direct Oral Anticoagulants Versus Vitamin K Antagonists for Venous Thromboembolism in China. Front Pharmacol 2021;12:716224. [PMID: 34744710 DOI: 10.3389/fphar.2021.716224] [Reference Citation Analysis]
6 Feng WW, Zhang Y, Tang JF, Zhang CE, Dong Q, Li RY, Xiao XH, Peng C, Dong XP, Yan D. Combination of chemical fingerprinting with bioassay, a preferable approach for quality control of Safflower Injection. Analytica Chimica Acta 2018;1003:56-63. [DOI: 10.1016/j.aca.2017.11.069] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
7 Labberton L, Kenne E, Long AT, Nickel KF, Di Gennaro A, Rigg RA, Hernandez JS, Butler L, Maas C, Stavrou EX, Renné T. Neutralizing blood-borne polyphosphate in vivo provides safe thromboprotection. Nat Commun 2016;7:12616. [PMID: 27596064 DOI: 10.1038/ncomms12616] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 5.8] [Reference Citation Analysis]
8 Huang Q, Cheng Q, Zhang X, Yin H, Wang LH, Wang R. Alleviation of Polycation-Induced Blood Coagulation by the Formation of Polypseudorotaxanes with Macrocyclic Cucurbit[7]uril. ACS Appl Bio Mater 2018;1:544-8. [PMID: 34996189 DOI: 10.1021/acsabm.8b00401] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
9 Mehta AY, Mohammed BM, Martin EJ, Brophy DF, Gailani D, Desai UR. Allosterism-based simultaneous, dual anticoagulant and antiplatelet action: allosteric inhibitor targeting the glycoprotein Ibα-binding and heparin-binding site of thrombin. J Thromb Haemost 2016;14:828-38. [PMID: 26748875 DOI: 10.1111/jth.13254] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
10 Bai L, Yang XH, Zhou YQ, Cui XR, Fu LZ, Zhang JD. Safety and Efficacy Evaluation of Antithrombotic Therapy with Rivaroxaban and Clopidogrel After PCI in Chinese Patients. Clin Appl Thromb Hemost 2022;28:10760296221074681. [PMID: 35200040 DOI: 10.1177/10760296221074681] [Reference Citation Analysis]
11 Verespy S 3rd, Mehta AY, Afosah D, Al-Horani RA, Desai UR. Allosteric Partial Inhibition of Monomeric Proteases. Sulfated Coumarins Induce Regulation, not just Inhibition, of Thrombin. Sci Rep 2016;6:24043. [PMID: 27053426 DOI: 10.1038/srep24043] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
12 Baber U, Mastoris I, Mehran R. Balancing ischaemia and bleeding risks with novel oral anticoagulants. Nat Rev Cardiol 2015;12:66. [PMID: 25445132 DOI: 10.1038/nrcardio.2014.204] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
13 Mobashsher AT, Mahmoud A, Abbosh AM. Portable Wideband Microwave Imaging System for Intracranial Hemorrhage Detection Using Improved Back-projection Algorithm with Model of Effective Head Permittivity. Sci Rep 2016;6:20459. [PMID: 26842761 DOI: 10.1038/srep20459] [Cited by in Crossref: 37] [Cited by in F6Publishing: 12] [Article Influence: 6.2] [Reference Citation Analysis]
14 Mobashsher AT, Abbosh AM. On-site Rapid Diagnosis of Intracranial Hematoma using Portable Multi-slice Microwave Imaging System. Sci Rep 2016;6:37620. [PMID: 27897197 DOI: 10.1038/srep37620] [Cited by in Crossref: 30] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
15 Farinola N, Caughey GE, Bell JS, Johns S, Hauta-Aho M, Shakib S. Influence of stroke and bleeding risk on prescribing of oral anticoagulants in older inpatients; has the availability of direct oral anticoagulants changed prescribing? Ther Adv Drug Saf 2018;9:113-21. [PMID: 29387336 DOI: 10.1177/2042098617747835] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
16 Wong JM, Maddox TM, Kennedy K, Shaw RE. Comparing Major Bleeding Risk in Outpatients With Atrial Fibrillation or Flutter by Oral Anticoagulant Type (from the National Cardiovascular Disease Registry's Practice Innovation and Clinical Excellence Registry). Am J Cardiol 2020;125:1500-7. [PMID: 32276760 DOI: 10.1016/j.amjcard.2020.02.028] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
17 Bentley R, Hardy LJ, Scott LJ, Sharma P, Philippou H, Lip GYH. Drugs in phase I and II clinical development for the prevention of stroke in patients with atrial fibrillation. Expert Opin Investig Drugs 2021;:1-13. [PMID: 33682570 DOI: 10.1080/13543784.2021.1897786] [Reference Citation Analysis]
18 Aboyans V, Brodmann M, De Carlo M, Clement D, Mazzolai L, van Bortel L, van Sambeek MRH, Vlachopoulos C; On Behalf the ESC Working Group of Peripheral Circulation. The year in cardiology 2014: peripheral circulation. European Heart Journal 2015;36:591-7. [DOI: 10.1093/eurheartj/ehu515] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
19 Wang Y, Xie F, Kong MC, Lee LH, Ng HJ, Ko Y. Patient-reported health preferences of anticoagulant-related outcomes. J Thromb Thrombolysis 2015;40:268-73. [PMID: 25875937 DOI: 10.1007/s11239-015-1191-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]